Zoetis EVP granted 593 Phantom Stock Units

Zoetis Inc. Executive Vice President Ferran Astorga Jeannette received a grant of 593.1735 Phantom Stock Units on Zoetis common stock, valued at $38.20 per unit.

Accepted by SEC EDGAR 03/31/2026 - 04:46 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Zoetis Inc. Executive Vice President Ferran Astorga Jeannette received a grant of 593.1735 Phantom Stock Units on Zoetis common stock, valued at $38.20 per unit. Each unit represents a fraction of a phantom share plus cash-equivalent investments, referencing Zoetis’ market value.

The grant corresponds to 199.9050 underlying shares of common stock, bringing the executive’s total Phantom Stock Units to 2,245.8327. These units, acquired under the Zoetis Supplemental Savings Plan, are cash-settled after separation from service and may be reallocated among investment funds subject to Zoetis’ transfer limits.

Insider Trade Summary

Grant/Award: 593.1735 shares

Grant/Award 1 txn

Insider Ferran Astorga Jeannette

Role Executive Vice President

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Unit	593.1735	$38.20	$23K

Holdings After Transaction: Phantom Stock Unit — 2,245.8327 contracts (Direct)

Footnotes (2)

1. F1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
2. F2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Key Figures

Phantom Stock Units granted: 593.1735 units Reference value per unit: $38.20 per unit Underlying common stock: 199.9050 shares +2 more

5 metrics

Phantom Stock Units granted 593.1735 units Grant on 2026-03-27 as compensation

Reference value per unit $38.20 per unit Phantom Stock Unit valuation reference

Underlying common stock 199.9050 shares Shares referenced by granted phantom units

Total Phantom Stock Units after grant 2,245.8327 units Holdings following reported transaction

Cash-equivalent portion of unit value around 5% Typical share of cash-equivalent investments per unit

Key Terms

Phantom Stock Unit, Zoetis Supplemental Savings Plan, cash-equivalent investments, separation from service

4 terms

Phantom Stock Unit financial

"These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash..."

Zoetis Supplemental Savings Plan financial

"These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash..."

cash-equivalent investments financial

"plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value..."

separation from service financial

"are settled in cash following the reporting person's separation from service and may be transferred..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Zoetis (ZTS) Executive Vice President Ferran Astorga receive in this Form 4?

Ferran Astorga received 593.1735 Phantom Stock Units tied to Zoetis common stock at $38.20 per unit. These units are a compensation-related grant, increasing total Phantom Stock Units held to 2,245.8327 under the Zoetis Supplemental Savings Plan.

How are Zoetis (ZTS) Phantom Stock Units from this filing valued?

Each Phantom Stock Unit’s value is based on Zoetis common stock plus cash-equivalent investments, typically around 5% of total value. The unit’s overall worth moves with Zoetis’ share price and the performance of the small cash-equivalent portion.

When are the Zoetis (ZTS) Phantom Stock Units settled for Ferran Astorga?

The Phantom Stock Units are settled in cash after Ferran Astorga’s separation from service. At that time, the cash value is determined by Zoetis’ market price and the value of the associated cash-equivalent investments within each unit.

Does the Zoetis (ZTS) Form 4 involve actual common stock or only phantom units?

The transaction involves Phantom Stock Units referencing Zoetis common stock, not direct share purchases or sales. Each unit represents a fraction of a phantom share plus a small cash-equivalent component, and is ultimately settled in cash rather than stock.

How many underlying Zoetis (ZTS) shares are tied to the Phantom Stock Units granted?

The reported 593.1735 Phantom Stock Units correspond to 199.9050 underlying shares of Zoetis common stock. This linkage shows how the phantom units track the economic value of a specific number of Zoetis shares for compensation purposes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ferran Astorga Jeannette

(Last) (First) (Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY NEW JERSEY 07054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Unit(1)	(2)	03/27/2026		A		593.1735		(1)	(1)	Common Stock	199.905	$38.2	2,245.8327	D

Explanation of Responses:

1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	03/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)